Lucid Diagnostics Inc. (LUCD)

Lucid Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	33.4	34.71	22.36	18.9	22.47	53.66
Short-Term Investments	1.07	0.99	1.02	1.98	1.33	1.12
Cash & Short-Term Investments	34.47	35.69	23.38	20.88	23.81	54.77
Cash Growth	6.86%	52.68%	11.98%	-12.30%	-56.54%	23817.90%
Accounts Receivable	1.09	0.64	0.05	0.05	0.02	0.2
Other Receivables	-	-	0.36	-	-	-
Receivables	1.09	0.64	0.41	0.05	0.02	0.2
Inventory	0.48	0.35	0.34	0.28	0.11	0.49
Prepaid Expenses	0.19	0.42	0.44	0.61	0.05	1.58
Other Current Assets	0.39	0.36	0.58	0.27	0.37	0.26
Total Current Assets	36.62	37.47	25.15	22.07	24.36	57.3
Property, Plant & Equipment	2.21	2.62	3.7	2.64	3.6	0.97
Other Intangible Assets	0.11	0.32	0.74	1.42	3.45	-
Other Long-Term Assets	0.01	0.05	1.13	1.13	1.11	0.73
Total Assets	38.95	40.45	30.72	27.27	32.51	59

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.67	0.97	1.24	1.15	1.06	1.49
Accrued Expenses	2.44	2.32	2.41	12.61	6.12	2.15
Short-Term Debt	23.5	24	18.6	13.95	-	-
Current Portion of Leases	0.91	0.89	0.85	1.11	0.96	-
Other Current Liabilities	-	0.4	0.42	0.58	0.28	0.62
Total Current Liabilities	27.52	28.58	23.52	29.38	8.43	4.26
Long-Term Leases	0.5	0.93	1.8	0.2	1.04	-
Total Liabilities	28.02	29.51	25.32	29.58	9.46	4.26

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.19	0.13	0.06	0.04	0.04	0.04
Additional Paid-In Capital	323.41	230.87	154.68	129.76	121.08	96.61
Retained Earnings	-312.68	-274.34	-203.77	-150.74	-98.08	-41.9
Total Common Equity	10.93	-43.34	-49.03	-20.94	23.05	54.74
Shareholders' Equity	10.93	10.94	5.39	-2.31	23.05	54.74
Total Liabilities & Equity	38.95	40.45	30.72	27.27	32.51	59

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	24.91	25.82	21.25	15.26	2	-
Net Cash (Debt)	9.56	9.87	2.12	5.62	21.81	54.77
Net Cash Growth	103.21%	364.88%	-62.22%	-74.22%	-60.19%	23817.90%
Net Cash Per Share	0.07	0.10	0.04	0.13	0.60	2.94
Filing Date Shares Outstanding	190.95	170.36	86.86	45.91	41.3	37.43
Total Common Shares Outstanding	190.76	131.1	63.07	42.33	40.52	34.92
Working Capital	9.11	8.89	1.62	-7.31	15.93	53.04
Book Value Per Share	0.06	-0.33	-0.78	-0.49	0.57	1.57
Tangible Book Value	10.82	-43.65	-49.76	-22.36	19.6	54.74
Tangible Book Value Per Share	0.06	-0.33	-0.79	-0.53	0.48	1.57
Machinery	-	2.36	2.18	2.1	1.88	0.95
Construction In Progress	-	-	-	-	-	0.02
Leasehold Improvements	-	0.03	0.03	0	0	0

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error